MSK Doctors (03-300-010-048), a leading UK clinic collective that specialises in regenerative orthopaedic medicine treatments, is now offering Arthrosamid injections for fast relief of severe knee pain.

Sleaford, United Kingdom, March 4, 2025 -- MSK Doctors and their founder, Professor Paul Lee, MBBCh, MRCS, MFSEM (UK), MSc (Sports Med), PhD, FEBOT, FRCS (Tr & Orth), are pleased to be leading the use of Arthrosamid in the United Kingdom and to be giving both prospective patients and practitioners information about this innovative gel injection.

More information is available at https://mskdoctors.com/treatments/arthrosamid

While many treatments for knee pain, including that caused by knee osteoarthritis, focus on masking or hiding the symptoms by dulling the pain messages that are sent from the knee to the brain, Arthrosamid is instead designed to restore the damage that has been caused to the knee by osteoarthritis, specifically to the synovial membrane; the tissue that lines the bones of the knee joint.

It is also designed to be a regenerative solution, which encourages the long-term healing and restoration of this integral membrane, and therefore the knee joint. In this way, the treatment offers both fast and lasting relief from pain.

As a spokesperson for MSK Doctors explained in a new guide to the gel injections, Arthrosamid can support tissue regeneration by providing a structural framework for the synovial membrane. Plus, its effectiveness, safety, and long-term benefits have been backed by both clinical research and patient success stories, making it a promising new treatment option.

Professor Paul Lee and MSK Doctors are now offering Arthrosamid in all of their specialist clinics, including their new, focused ASMK Arthrosamid Clinic, which is located on Harley Street in central London.

Their expert clinicians offer no-wait and no-referral consultations and have in-house MRI technology to assess whether a new patient could be a suitable candidate for the pain-relieving technique. As a teaching fellow, Professor Paul Lee can also assist new practitioners who would like to offer the novel treatment in their own clinic/s.

“In my practice, I’m passionate about utilising evidenced-based methods with advanced technology and Arthrosamid certainly fits into this novel treatment model,” said Professor Paul Lee himself.

He added, “Knee osteoarthritis can have a significant impact on a patient’s quality of life, causing discomfort which can make everyday activities challenging. However, many people are reluctant to undergo invasive surgery with the intensive recovery required. This is what prompted me to look at other evidence-based alternatives. This treatment really can provide long-acting and sustained pain relief and so far, I’m delighted with my patients’ recovery and the improvements they’ve reported.”

The leading professor, specialist and surgeon encourages people in the UK who are living with knee pain and/or joint stability and mobility issues to reach out to his expert team and find their closest MSK Doctors clinic.

For more information, visit https://mskdoctors.com/

Contact Info:
Name: Bethan Lee
Email: Send Email
Organization: MSK Doctors
Address: MSK House London Road Silk Willoughby, Sleaford, Lincolnshire, Sleaford, England NG34 8NY, United Kingdom
Website: https://www.mskdoctors.com

Source: PressCable

Release ID: 89154544

If you come across any problems, discrepancies, or concerns related to the content contained within this press release that necessitate action or if a press release requires takedown, we strongly encourage you to reach out without delay by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our committed team will be readily accessible round-the-clock to address your concerns within 8 hours and take appropriate actions to rectify identified issues or support with press release removals. Ensuring accurate and reliable information remains our unwavering commitment.